Robocath

7 articles about Robocath

• Robocath successfully carries out its first robotic coronary angioplasties in humans

  9/24/2019

  The procedures were performed at Rouen University Hospital and Clinique Pasteur in Toulouse (France) and precede the first clinical study of its kind to be conducted in Europe

• Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

  9/3/2019

  Robocath announces that it has raised €5 million to support the rollout of its robotic platform in strategic European target markets.

• Robocath strengthens its medical advisory board with international interventional cardiology experts

  5/22/2019

  The board plays a key role in defining the clinical strategy of the company.

• Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform

  5/23/2018

  Robocath announces during the EuroPCR congress that its first robotic solution, R-OneTM, met all its primary efficacy and safety endpoints in the first pre-clinical study.

• Robocath Sets Up Medical Advisory Board Composed of International Interventional Cardiology Key Leaders

  1/30/2018

  Robocath announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology.

• Robocath Raises a Total of €6.4 Million ($7.6M) in 2017

  12/6/2017

  This latest financial contribution supplements the $5.6M raised by Robocath in a previous round of fundraising in May.

• Robocath Appoints Pascal Guy As CEO

  12/13/2016